The placebo has a checkered history in health care, but the new field of placebo research may change that. Groundbreaking studies from the Program in Placebo Studies and the Therapeutic Encounter (PiPS), a joint venture between Beth Israel Deaconess Medical Center and Harvard University, are confirming what nurses have always known: Healing is facilitated by the nursing practices of listening, touch, and compassion. In this editorial, we provide a brief history of the placebo, its current use in research, and the relevance of new findings for nursing practice and research.
Initially, the placebo was given to patients when few alternative treatments were available (Pohlman, Cibulka, Palmer, Lorenz, & SmithBattle, 2013) . Although the clinical use of "sugar" pills or "fake" treatments is considered unethical practice today because of the deception involved, the placebo is widely used in research. Placebos are frequently used to gauge the effectiveness of "real" drugs and other therapies in randomized clinical trials. Participant improvements in clinical trials may be seen with both the "real" drug and with the placebo, and sometimes, the improvement with both is considered significant (see http://programinplacebostudies.org/publications/). For example, in one study, patients with irritable bowel syndrome (IBS) who were given placebo pills were told that patients sometimes benefit Clinical Nursing Research 25 (6) from a placebo because of mind-body interactions. Interestingly, IBS symptoms declined among patients receiving this "open-label" placebo, and symptomatic relief was comparable with standard IBS medications (Kaptchuk et al., 2010) . These and other findings have raised perplexing questions: If "real" drugs are effective based on pharmacologically active ingredients, what then explains the fact that some patients benefit from being given inert substances or placebos? Scientists have attempted to explain, or explain away, the "placebo response" for years; innovative studies by the PiPS researchers are directly examining the clinical response to placebos and discovering the neurobiological pathways that explain the response (Kaptchuk & Miller, 2015; Kirsch, 2013) .
These findings invite nurses to consider the therapeutic responses to clinical encounters that rarely get the attention they deserve, including the power of listening, compassion, and healing environments. Nurses are bringing attention to this paradigm-changing research and are beginning to articulate how nurses' words and actions potentiate or dampen this response Pohlman et al., 2013) . This relational aspect of care has always been central to nursing practice and education, but is increasingly sidelined as care becomes more technical and evidence-based.
Illness and healing are saturated with meanings that are conveyed and expressed through health care practices and relationships. In a culture like ours, pill taking is deeply entrenched in our rituals of healing; that is, we expect that prescribed pills will relieve our symptoms (Pohlman et al., 2013) . As nurses, we also know that good nursing care demands more than giving patients prescribed treatments and medications; we understand that each and every clinical encounter has the potential to evoke or suppress a healing response. Løgstrup (1956 Løgstrup ( /1997 ), a Danish philosopher, spoke to this issue:
By our attitude to the other person we help to determine the scope and hue of [her] world; we make it larger or smaller; bright or drab, rich or dull, threatening or secure. We help to shape his world not by theories and views but by our very attitude toward [her] . Herein lies the unarticulated and one might say anonymous demand that we take care of the life which trust has placed in our hands. (p. 18) At a time when nurses are being pulled away from the bedside toward encounters of a more "computerized" kind, groundbreaking studies on the placebo response may provide the evidence we need to advocate for more time with our patients and their families. Nurses should conduct nursing interventions which also examine the placebo response. Interventions to reduce pain, fatigue, nausea, or poor sleep could be designed to test this response. To illustrate, one group of patients would receive their nausea medication by nurses who express empathy and confidence in symptom improvement with reassuring words and sustained eye contact. All computerized charting would occur external to the patient's room. Another group of patients would receive the nausea medication by nurses who are turned toward the computer so that interactions are limited. A third group of patients would receive usual care (nausea medication and standard nurse interactions). Neurophysiologic measures and qualitative interviews would strengthen the study design and help to explain differential responses, including nocebo (or detrimental) effects. Nursing research along these lines would add to the emerging science on the placebo response, legitimate the therapeutic process, deepen our knowledge of the sentient body of the patient, and reveal the clinical skills and judgments that nurses make every day at the bedside. Similar studies would reduce the discordant spaces and wide gaps between biomedical science, the patients' experience of illness, and the healing response.
